SBS 2021 Part 1 – The Medical Dermatology Summit

February 5-7, 2021

Activity Overview

At The Medical Dermatology Summit, led by renowned clinical authorities, attendees will gain actionable knowledge on the most relevant topics in medical dermatology including the impact of COVID-19 on the dermatology industry, cutaneous oncology, hair restoration, and much more all from the safety of their home.

The summit will deliver an interactive educational experience that optimizes all the advantages of virtual education with live-streamed sessions, on-demand content, faculty Q&A, live engagement, and networking with key industry opinion leaders.

Target Audience

This symposium is designed for an audience of physicians, nurses and professional staff members of medical practices specializing in dermatology, pediatric dermatology, plastic surgery, cosmetic surgery and other dermatologic medical procedures.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Summarize new and emerging therapies for the treatment of acne.
  • Evaluate the efficacy and safety of acne treatments, including the need to appropriately modify therapy and practice antibiotic stewardship.
  • Describe recent advances in the treatment of actinic keratosis that have high levels of patient satisfaction, decreased treatment duration, and fewer side-effects.
  • List the pathogenic mechanisms of atopic dermatitis.
  • Review individualized treatment plans for patients with moderate-to-severe atopic dermatitis based on current guideline recommendations, the safety and efficacy of new and emerging treatment options, comorbidities, and patients' quality of life.
  • List current and emerging treatment options for alopecia areata.
  • Review and compare efficacy and safety of biologic agents, devices, and techniques currently available in hair restoration for androgenic alopecia.
  • Define the efficacy and safety of emerging treatment options for hidradenitis suppurativa.
  • Review the new and emerging treatment options for hyperhidrosis.
  • Summarize new and emerging therapies for the treatment of psoriasis.
  • Review the significance of addressing comorbidities as important components of psoriasis therapy.
  • Review the clinical presentation of rosacea in order to ensure timely diagnosis.
  • Summarize traditional, new and emerging therapies for the treatment of rosacea.
  • Define the efficacy and safety of the current and new treatment options for seborrheic keratosis.

Criteria for Success

Statements of credit will be awarded based on the participant's attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at  You must participate in the entire activity to receive credit. If you have questions about this CE activity, please contact AKH Inc. at

AKH Logo Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Jointly Accredited Provider

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 14 Interprofessional Continuing Education (IPCE) credit for learning and change.


AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 18.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


18.75 ANCC contact hours

Physician Assistant


AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 18.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Commercial Support

Full notification of commercial support will be provided in the final course syllabus.

* Please note the agenda, faculty and CE hours are subject to change